Watch Ticker

Atea Pharmaceuticals, Inc. Common Stock

Go to Atea Pharmaceuticals, Inc. Common Stock Website

$3.55

0.03 (0.85%)

Live

Previous Close

$3.49

Day Range

$3.45 - $3.58

Previous Day Range

$3.505 - $3.56

Market Cap

$301.2 million USD

Day Vol.

339640

Previous Day Vol.

281518

Currency

USD

Primary Exchange

Nasdaq

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Atea Pharmaceuticals - Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025

Atea Pharmaceuticals will host a conference call on August 7, 2025, to discuss second quarter 2025 financial results and provide a business update, focusing on their HCV treatment development program.

Related tickers: AVIR.

Read Full Article

N/A - Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America

Atea Pharmaceuticals has dosed the first patient in its global Phase 3 C-FORWARD trial evaluating a combination regimen for the treatment of hepatitis C virus (HCV). The regimen has the potential to be a best-in-class option with a short treatment duration, low risk of drug-drug interactions, and convenience.

Related tickers: AVIR.

Read Full Article

Trending Tickers

Please sign in to view